Increased prevalence of migraine in Marfan syndrome

International Journal of Cardiology

Volumn 136, Issue 3, 2009, Pages 330-334

  Vis, Jeroen C ^a,b   Timmermans, Janneke ^c   Post, Martijn C ^d   Budts, Werner ^e   Schepens, Marc A A M ^d   Thijs, Vincent ^e   Schonewille, Wouter J ^d   de Bie, Rob M A ^a   Plokker, Herbert W M ^d   Tijssen, Jan G P ^a   Mulder, Barbara J M ^a,f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Congenital heart disease; Marfan syndrome; Migraine; Prevalence; Risk

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIMIGRAINE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COUMARIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STRUCTURED QUESTIONNAIRE;

ADULT; AORTIC DISEASES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MARFAN SYNDROME; MIDDLE AGED; MIGRAINE WITH AURA; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 68049095011     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.037     Document Type: Article

References (25)

1. Russell M.B., Rasmussen B.K., Thorvaldsen P., and Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 24 3 (1995) 612-618
2. Wilmshurst P., and Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 100 2 (2001) 215-220
3. Post M.C., and Budts W. The relationship between migraine and right-to-left shunt: fact or fiction?. Chest 130 3 (2006) 896-901
4. Schwerzmann M., Nedeltchev K., and Meier B. Patent foramen ovale closure: a new therapy for migraine. Catheter Cardiovasc Interv 69 2 (2007) 277-284
5. Spence J.D., Wong D.G., Melendez L.J., Nichol P.M., and Brown J.D. Increased prevalence of mitral valve prolapse in patients with migraine. Can Med Assoc J 131 12 (1984) 1457-1460
6. Jacome D.E. Headache in Ehlers-Danlos syndrome. Cephalalgia 19 9 (1999) 791-796
7. Knudsen S., and Russell M.B. Increased risk of migraine in Marfan's syndrome?. Acta Neurol Scand 114 4 (2006) 281-286
8. Hermans H., Post M.C., Thijs V., Spaepen M., and Budts W.I. Increased prevalence of migraine in adult congenital heart disease. Heart 93 3 (2007) 361-362
9. Truong T., Slavin L., Kashani R., et al. Prevalence of migraine headaches in patients with congenital heart disease. Am J Cardiol 101 3 (2008) 396-400
10. van der Velde, Vriend J.W., Mannens M.M., Uiterwaal C.S., Brand R., and Mulder B.J. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol 20 6 (2005) 549-557
11. De Paepe A., Devereux R.B., Dietz H.C., Hennekam R.C., and Pyeritz R.E. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62 4 (1996) 417-426
12. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 Suppl 1 (2004) 9-160
13. Post M.C., Thijs V., Herroelen L., and Budts W.I. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 62 8 (2004) 1439-1440
14. Mortelmans K., Post M., Thijs V., Herroelen L., and Budts W. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 26 15 (2005) 1533-1537
15. Post M.C., Thijs V., Schonewille W.J., et al. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 66 2 (2006) 202-205
16. Wilmshurst P., and Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 100 2 (2001) 215-220
17. Reisman M., Christofferson R.D., Jesurum J., et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45 4 (2005) 493-495
18. van Karnebeek C.D., Naeff M.S., Mulder B.J., Hennekam R.C., and Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 84 2 (2001) 129-137
19. Pyeritz R.E., Fishman E.K., Bernhardt B.A., and Siegelman S.S. Dural ectasia is a common feature of the Marfan syndrome. Am J Hum Genet 43 5 (1988) 726-732
20. Oosterhof T., Groenink M., Hulsmans F.J., et al. Quantitative assessment of dural ectasia as a marker for Marfan syndrome. Radiology 220 2 (2001) 514-518
21. Wilson D.G., Bellamy M.F., Ramsey M.W., et al. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation 99 7 (1999) 909-915
22. Pierangeli G., Cevoli S., Zanigni S., et al. The role of cardiac diseases in the comorbidity between migraine and stroke. Neurol Sci 25 Suppl 3 (2004) S129-S131
23. Patel N.V., Bigal M.E., Kolodner K.B., Leotta C., Lafata J.E., and Lipton R.B. Prevalence and impact of migraine and probable migraine in a health plan. Neurology 63 8 (2004) 1432-1438
24. Snow V., Weiss K., Wall E.M., and Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 137 10 (2002) 840-849
25. Engelfriet P., and Mulder B. Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome?. Int J Cardiol 114 3 (2007) 300-302